(Q69743103)
Statements
Differences between in vivo and in vitro activation of cancer patient lymphocytes by recombinant interleukin 2: possible role for lymphokine-activated killer cell infusion in the in vivo-induced activation (English)
Gambacorti-Passerini C
Rivoltini L
Radrizzani M
Belli F
Sciorelli G
Ravagnani F
Galazka AR
Cascinelli N
1 September 1989